Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

METHYLPREDNISOLONE ACEPONATE for Dermatitis atopic: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 12 adverse event reports in the FDA FAERS database where METHYLPREDNISOLONE ACEPONATE was used for Dermatitis atopic.

Most Reported Side Effects for METHYLPREDNISOLONE ACEPONATE

Side Effect Reports % Deaths Hosp.
Steroid withdrawal syndrome 20 16.5% 0 5
Skin discolouration 17 14.1% 0 10
Erythema 16 13.2% 0 3
Pulmonary embolism 16 13.2% 0 10
Dyspnoea 15 12.4% 0 10
Deep vein thrombosis 14 11.6% 0 10
Musculoskeletal stiffness 14 11.6% 0 10
Peripheral swelling 14 11.6% 0 10
Coagulation test abnormal 13 10.7% 0 9
Diarrhoea 12 9.9% 8 8
Condition aggravated 11 9.1% 0 2
Hypotension 10 8.3% 8 9
Loss of personal independence in daily activities 10 8.3% 8 9
Pelvic venous thrombosis 10 8.3% 0 10
Pneumonia 10 8.3% 9 9

Other Indications for METHYLPREDNISOLONE ACEPONATE

Product used for unknown indication (42) Eczema (10) Immunosuppression (7)

Other Drugs Used for Dermatitis atopic

DUPILUMAB (179,563) UPADACITINIB (5,263) TRALOKINUMAB-LDRM (3,007) CRISABOROLE (2,139) ABROCITINIB (1,616) NEMOLIZUMAB-ILTO (1,596) RUXOLITINIB (740) TACROLIMUS (515) METHOTREXATE (400) CYCLOSPORINE (370)

Related Pages

METHYLPREDNISOLONE ACEPONATE Full Profile All Dermatitis atopic Drugs METHYLPREDNISOLONE ACEPONATE Demographics METHYLPREDNISOLONE ACEPONATE Timeline